As a child of Haitian immigrants in Queens, Rachelle Monteau watched her uncle struggle with leukemia.
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
